ALOX5 and atherosclerosis: New studies should consider enlarging the range of 5-LOX-expressing cells such as dendritic cells and should consider the interaction with other cell lines such as endothelial (i.e., atherosclerosis) or intestinal cells and microbiota (i.e., intestinal inflammation).